Treatment for Patients With Metastatic Thyroid Cancer
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This study is being done to find out the good and bad effects of an investigational drug that
is not approved for sale, called AG-013736. Tumors need blood vessels in order to continue to
grow, and AG-013736 is thought to work by playing a role in preventing new blood vessels from
growing. We want to see if AG-013736 has any effect on your disease by making your tumor
smaller and if so, for how long. We also want to test the safety [the effect on your body] of
AG-013736 and to measure the amount of AG-013736 that gets into your blood. AG-013736 has
been given to over 140 patients with cancer on other studies.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center